MYLAN 6725 MYLAN 6725
Pill imprint MYLAN 6725 MYLAN 6725 has been identified as Zonisamide 25 mg.
Zonisamide is used in the treatment of seizures; migraine prevention; benign essential tremor; parkinsonian tremor and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. Risk cannot be ruled out during pregnancy.
Zonisamide 25 mg is not subject to the Controlled Substances Act.
See also related documents.
Zonisamide Images
- Imprint:
-
MYLAN 6725
MYLAN 6725 - Strength:
- 25 mg
- Color:
- Purple
- Size:
- 12.00 mm
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-6725
- Inactive Ingredients:
- lactose anhydrous
ferrosoferric oxide
silicon dioxide
D&C Yellow No. 10
D&C Red No. 28
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
gelatin
magnesium stearate
microcrystalline cellulose
propylene glycol
shellac
sodium lauryl sulfate
titanium dioxide
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16590-0724 | Stat RX USA LLC (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Zonisamide resources
- Zonisamide (Wolters Kluwer)
- zonisamide (Cerner Multum)
- zonisamide (Micromedex) - Includes Dosage Information
- Zonisamide (AHFS DI)
- Zonisamide Capsules (FDA)
- Zonisamide (Wolters Kluwer)
Search Again
